Drug Database
J01FA09 clarithromycin
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Clarithromycin 125 mg/5 ml granules for oral suspension
- POM Clarithromycin 125 mg/5ml suspension
- POM Clarithromycin 125mg/5ml Oral Suspension
- POM Clarithromycin 250 mg film-coated tablets
- POM Clarithromycin 250 mg Film-coated Tablets
- POM Clarithromycin 250 mg/5 ml granules for oral suspension
- POM Clarithromycin 250 mg/5ml suspension
- POM Clarithromycin 250mg
- POM Clarithromycin 250mg Film-coated Tablets
- POM Clarithromycin 250mg Film-coated Tablets
- POM Clarithromycin 250mg/5ml Oral Suspension
- POM Clarithromycin 500 mg film-coated tablets
- POM Clarithromycin 500 mg Film-coated Tablets
- POM Clarithromycin 500 mg powder for concentrate for solution for infusion
- POM Clarithromycin 500 mg Powder for Concentrate for Solution for Infusion
- POM Clarithromycin 500 mg Powder for Concentrate for Solution for Infusion.
- POM Clarithromycin 500 mg, Powder for Concentrate for Solution for Infusion
- POM Clarithromycin 500mg
- POM Clarithromycin 500mg Film-coated Tablets
- POM Clarithromycin 500mg Film-coated Tablets
- POM Clarithromycin 500mg Powder for concentrate for solution for infusion
- POM Clarithromycin 500mg powder for solution for infusion vials
- POM Klaricid Adult Sachet 250 mg
- POM Klaricid IV 500mg
- POM Klaricid XL 500mg tablets
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).